Oracle says AI will save it from the SaaSpocalypse, not bring it on36m ago Congress Is Suddenly Waking Up to the AI Doomsday Threat1h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself1h ago Extreme Networks’ Agent ONE Coworker moves AI networking from dashboards to answers1h ago Introducing ChatGPT for Financial Services1h ago Tesla unveils driverless Cybercab in Japan for 1st time2h ago The AI safety vibe shift2h ago Sam Altman met with top power utilities about securing the electrical grid. He offered one possible solution: OpenAI's cyber services.2h ago OpenAI Is Open to Slowing Cutting-Edge AI, CEO Sam Altman Tells Staff3h ago Tencent-Backed Chipmaker Enflame Jumps 188% in Shanghai Debut3h ago Salesforce introduces Enterprise AI Harness, AI Control Plane3h ago The Race for the Next Big Weight-Loss Drug Is On—and China Wants In3h ago How Social Media Platforms Are Identifying AI Content4h ago DeepSeek launches V4.1-Flash and retires V4-Pro, its flagship model4h ago

Oracle says AI will save it from the SaaSpocalypse, not bring it on36m ago Congress Is Suddenly Waking Up to the AI Doomsday Threat1h ago Don’t ask ChatGPT 'What should I do?' — this simple prompt helps you make better decisions yourself1h ago Extreme Networks’ Agent ONE Coworker moves AI networking from dashboards to answers1h ago Introducing ChatGPT for Financial Services1h ago Tesla unveils driverless Cybercab in Japan for 1st time2h ago The AI safety vibe shift2h ago Sam Altman met with top power utilities about securing the electrical grid. He offered one possible solution: OpenAI's cyber services.2h ago OpenAI Is Open to Slowing Cutting-Edge AI, CEO Sam Altman Tells Staff3h ago Tencent-Backed Chipmaker Enflame Jumps 188% in Shanghai Debut3h ago Salesforce introduces Enterprise AI Harness, AI Control Plane3h ago The Race for the Next Big Weight-Loss Drug Is On—and China Wants In3h ago How Social Media Platforms Are Identifying AI Content4h ago DeepSeek launches V4.1-Flash and retires V4-Pro, its flagship model4h ago

Healthcare AI Research

How AI is shortening drug discovery timelines in China

AI News (TechForge)Published Jul 27, 2026

Chinese pharmaceutical companies are leveraging AI technologies to accelerate drug discovery, significantly reducing the time required to develop new medications. This integration of AI is transforming traditional research methods and speeding up the path from lab to market.

#china #drug-discovery #pharmaceutical-companies

More in Healthcare

Google DeepMind Releases AlphaGenome Atlas Mapping 9 Billion Human DNA

Forbes8h ago

Healthcare3 min read

Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his

TechCrunch6h ago

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources1d ago